Dr. Ron Petersen at Mayo Clinic shares with FOX 9 about what they're seeing in patients with the new Alzheimer's drugs ...

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

A new report shows up to 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases.

A survey of 1700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's.

Most Americans want to know if they're destined to lose their brain power to Alzheimer's disease, according to an annual ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

Eli Lilly has requested Europe's medicines regulator to re-examine its opinion on the company's Alzheimer's drug, the agency ...

The father of the dominant theory of Alzheimer’s disease told another eminent researcher he is “causing harm” by criticizing ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with early-stage disease.

A new Alzheimer’s Association report shows the number of people living with Alzheimer’s disease has reached 7.2 million ...